We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$153M
AUM Growth
-$2.65M
Cap. Flow
-$1.5M
Cap. Flow %
-0.98%
Top 10 Hldgs %
30.88%
Holding
83
New
1
Increased
12
Reduced
17
Closed
7

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$2.06M
2
PCP
PRECISION CASTPARTS CORP
PCP
+$1.6M
3
ARG
Airgas Inc
ARG
+$825K
4
DD
Du Pont De Nemours E I
DD
+$496K
5
KEX icon
Kirby Corp
KEX
+$460K

Top Sells

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$1.33M
2
RRX icon
Regal Rexnord
RRX
+$1.32M
3
FMC icon
FMC
FMC
+$1.29M
4
SLB icon
SLB Ltd
SLB
+$651K
5
CLH icon
Clean Harbors
CLH
+$626K

Sector Composition

Rank Sector Weight
1 Industrials 23.6%
2 Healthcare 20.02%
3 Materials 15.08%
4 Technology 13.1%
5 Energy 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MHK icon
1
Mohawk Industries
MHK
$7.97B
$5.63M 3.69%
29,500
– –
EMR icon
2
Emerson Electric
EMR
$85.7B
$5M 3.28%
90,200
+35,000
+63% +$2.06M
KEX icon
3
Kirby Corp
KEX
$7.01B
$4.91M 3.21%
63,985
+5,800
+10% +$460K
ARG
4
DELISTED
Airgas Inc
ARG
$4.8M 3.14%
45,375
+7,900
+21% +$825K
BCR
5
DELISTED
CR Bard Inc.
BCR
$4.73M 3.1%
27,700
– –
IFF icon
6
International Flavors & Fragrances
IFF
$20.3B
$4.63M 3.03%
42,325
-500
-1% -$57.7K
XRAY icon
7
Dentsply Sirona
XRAY
$2.79B
$4.53M 2.97%
87,865
– –
IHS
8
DELISTED
IHS INC CL-A COM STK
IHS
$4.51M 2.96%
35,095
-50
-0.1% -$6.25K
LH icon
9
Labcorp
LH
$25B
$4.3M 2.82%
41,278
-2,852
-6% -$297K
BDX icon
10
Becton Dickinson
BDX
$46.6B
$4.11M 2.69%
29,756
– –
PCP
11
DELISTED
PRECISION CASTPARTS CORP
PCP
$3.94M 2.58%
19,725
+7,600
+63% +$1.6M
EW icon
12
Edwards Lifesciences
EW
$51.1B
$3.91M 2.56%
164,550
-13,500
-8% -$305K
APD icon
13
Air Products & Chemicals
APD
$64.7B
$3.84M 2.51%
30,322
-9,729
-24% -$1.33M
SLB icon
14
SLB Ltd
SLB
$73B
$3.68M 2.41%
42,673
-7,210
-14% -$651K
MKC icon
15
McCormick & Company Non-Voting
MKC
$13.8B
$3.63M 2.37%
89,550
– –
ROP icon
16
Roper Technologies
ROP
$38.6B
$3.56M 2.33%
20,658
– –
LII icon
17
Lennox International
LII
$14.8B
$3.48M 2.28%
32,350
-500
-2% -$55.5K
EPAM icon
18
EPAM Systems
EPAM
$5.51B
$3.46M 2.27%
48,550
-2,800
-5% -$192K
TMO icon
19
Thermo Fisher Scientific
TMO
$214B
$3.36M 2.2%
25,870
– –
FMC icon
20
FMC
FMC
$1.29B
$3.09M 2.02%
67,796
-26,058
-28% -$1.29M
DHR icon
21
Danaher
DHR
$139B
$2.97M 1.94%
51,598
– –
HEI icon
22
HEICO Corp
HEI
$50.1B
$2.9M 1.9%
121,216
– –
PTC icon
23
PTC
PTC
$16.2B
$2.8M 1.84%
68,340
-3,200
-4% -$127K
PLL
24
DELISTED
PALL CORP
PLL
$2.54M 1.67%
20,450
-2,100
-9% -$237K
MON
25
DELISTED
Monsanto Co
MON
$2.53M 1.66%
23,734
+2,633
+12% +$305K
1
2 3 4

Similar funds

TCB
Texas Capital Bancshares Dallas, Texas $254M AUM 27.01% 1-Year Est. Return
OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
SSW
Smith Shellnut Wilson Ridgeland, Mississippi $260M AUM 19.19% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WS
Wela Strategies Atlanta, Georgia $264M AUM 16.32% 1-Year Est. Return
MTWM
Masso Torrence Wealth Management Marlton, New Jersey $240M AUM 26.41% 1-Year Est. Return
KSWA
Kathleen S. Wright Associates Pittsburgh, Pennsylvania $270M AUM 12.59% 1-Year Est. Return
GA
Guerra Advisors Miami, Florida $271M AUM 27.78% 1-Year Est. Return

Stone Run Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Stone Run Capital held 83 positions worth $153M, down 1.7% from $155M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Stone Run Capital's Q2 2015 filing shows 1 new, 12 increased, 17 reduced and 7 closed positions. Its largest new stake was AbbVie: 4,300 shares worth $289K. The largest sale was Air Products & Chemicals, an estimated $1.33M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Materials.

  • Stone Run Capital's largest Q2 2015 buy was AbbVie: 4,300 shares worth $289K.
  • Stone Run Capital added most to Emerson Electric in Q2 2015, an estimated $2.06M increase.
  • Stone Run Capital's biggest Q2 2015 reduction was Air Products & Chemicals, cutting an estimated $1.33M.
  • Stone Run Capital fully exited Regal Rexnord in Q2 2015, selling an estimated $1.32M.
  • Stone Run Capital's ten largest holdings make up 31% of its $153M portfolio in Q2 2015.
  • Stone Run Capital opened 1 new position and closed 7 in Q2 2015.
  • Stone Run Capital's portfolio value fell 1.7% quarter-over-quarter to $153M.

Based on Stone Run Capital's 13F filing for Q2 2015, filed 14 Aug 2015.